https://www.pharmaceutical-technology.com/data-insights/octapharma-files-patent-for-gene-modification-method-using-crispr-cas-for-cells-with-3-alleles/
Discover Octapharma AG's groundbreaking patent for using CRISPR/Cas to modify genes with at least three alleles in cells, enabling production of therapeutic...
octapharma aggene modificationpatentmethodcrispr